Accelerated marrow adipogenesis has been associated with ageing and osteoporosis and is thought to be because of an imbalance between adipogenic and osteogenic differentiation of mesenchymal stem cell (MSCs). We have previously found that lysyl oxidase (Lox) inhibition disrupts BMP4-induced adipocytic lineage commitment and differentiation of MSCs. In this study, we found that lox inhibition dramatically up-regulates BMP4-induced expression of CCAAT/enhancer binding protein (C/EBP) homologous protein 10 (CHOP-10), which then promotes BMP4-induced osteogenesis of MSCs both in vitro and in vivo. Specifically, Lox inhibition or CHOP-10 up-regulation activated Wnt/β-catenin signalling to enhance BMP4-induced osteogenesis, with pro-adipogenic p38 MAPK and Smad signalling suppressed. Together, we demonstrate that Lox/CHOP-10 crosstalk regulates BMP4-induced osteogenic and adipogenic fate determination of MSCs, presenting a promising therapeutic target for osteoporosis and other bone diseases.
risk related to higher BMP doses, have also been reported. 12 The above studies indicate that enhancing pro-osteogenic and blocking pro-adipogenic effects with a lower dose of BMPs may be effective for clinical use of BMPs in bone disorders.
Lysyl oxidase (Lox) is synthesized and secreted as a 50 kD pro-enzyme (Pro-Lox) into the extracellular environment followed by enzymatic cleavage yielding the 32 kD mature and active Lox enzyme (Ma-Lox) and the 18 kD pro-peptide (Lox-PP). 13 The mature, 32 kD Lox catalyses the cross-linking of elastin and collagen, which is indispensable for the structural integrity and function of bone tissue. 14 We have previously reported that Lox promotes BMP2/4-induced adipocytic lineage commitment of C3H10T1/2 MSCs and that knockdown of Lox disrupts this commitment process. 10 Therefore, based on the theoretical inverse balance between adipogenic and osteogenic programming, 6 it raises a question whether Lox inhibition would promote 
| MATERIALS AND METHODS

| Animal studies
Mice were housed in a controlled environment (12 hours light/dark cycle, 60%-70% humidity). For high-fat diet-induced obesity and osteoporosis, 6-week-old male C57BL/6J mice were fed a high-fat diet (HFD, SLACOM, 51% kcal from fat) for 10 months, with mice fed a normal chow diet (NCD, SLACOM, 10% kcal from fat) used as controls. To examine the effect on bone of Lox inhibition when combined with elevated levels of BMP4 in vivo, we used previously described Fabp4-driven, male BMP4-Tg mice, 15 which also constitutively overexpress BMP4 in bone marrow adipose tissue, providing a higher concentration of BMP4 in local bone environment. We screened the mice by PCR using primers (Fabp4-BMP4 tg: cagtgatcattgccagggagaacc; gcctcctagcaggacttggcta), control mice were non-Tg littermates. In this study, to avoid the influence of oestrogen on bone formation, 16, 17 only the male mice was used. For β-aminopropionitrile (BAPN, Sigma-Aldrich, St. Louis, MO, USA) administration, 6-week-old male BMP4-Tg mice were daily injected ip with BAPN (100 mg/kg/d) or PBS control for 2 weeks. 18 Following treatment, the right femurs of mice were subjected to micro-CT analysis. For all in vivo experiments, 3-5 technical replicates were performed in each independent experiment. All animal experiments were approved by the Animal Care and Use Committee of Fudan University Shanghai Medical College and followed the National
Institute of Health guidelines on the care and use of animals.
| Cell culture and induction of commitment/ differentiation
Inguinal white adipose tissue (iWAT) was obtained from 6-to 8-week-old male C57BL/6J mice. Fat pads were minced and digested for 40 minutes at 37°C (1 mg/mL Collagenase IV (Sigma-Aldrich, St.
Louis, MO, USA) in DMEM). The cell suspension was passed through a 100-μm filter and centrifuged at 500 × g for 5 minutes at 4°C. The SVF pellets were resuspended in F12/DMEM with 10% foetal bovine serum (FBS). C3H10T1/2 mesenchymal stem cells were cultured in DMEM containing 10% calf serum. Primary bone marrow stromal cells (BMSCs) isolated from 6-week-old male C57BL/6J mice were cultured in a fresh alpha-minimum essential medium (α-MEM) containing 10% FBS. When BMSCs reach 80%-90% confluent, they were passaged and used in the experiments below.
To induce lineage commitment, SVFs or C3H10T1/2 cells were seeded at 30% confluence and cultured with or without purified recombinant BMP4 (10 ng/mL) until 2-day post-confluence (day 0).
To induce adipocyte differentiation, C3H10T1/2 cells or SVF cells (day 0) were treated according to a previously described protocol (MDI), with Oil Red O staining conducted to detect lipid droplets. 
| RNA interference
Stealth siRNA duplexes specific for mouse Lox were designed and synthesized by Invitrogen. The sequence for successful Lox RNAi knockdown was GCGGAUGUCAGAGACUAUGACCACA. 10 Stealth siRNA-negative control duplexes with similar GC content were used as control. SVF or C3H10T1/2 cells were transfected at 30%~50% confluence with siRNA oligonucleotides using Lipofectamine RNAi MAX according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA).
| Western blotting
Both cell and tissue extracts were generated using lysis buffer containing 50 mmol/L Tris-HCl (pH 6.8), 2% SDS, 100 mmol/L NaF, 
| Plasmid construction
MSCV-mature Lox was generated as previously described. 19 The MSCV-CHOP-10 expression plasmid was generated using standard DNA cloning techniques. Briefly, the mouse cDNA for CHOP-10 was amplified and subsequently cloned into the pMSCV-puro retroviral vector between the XhoI (5′-end) and EcoRI (3′-end) restriction sites using the following primers: 5′-CctcgagGATGGCAGCTGAGTC CCTGCCTTTCACCT-3′(forward), 5′-GgaattcCTCATGCTTGGTGCAGG CTGACCAT-3′(reverse). 
| Q-PCR
| Micro-CT
The 4% paraformaldehyde-fixed femurs were subjected to micro-CT analysis. Bone parameters of the femur metaphysis were quantified ex vivo using high-resolution, X-ray micro-computed tomography were then used to quantify bone micro-architecture.
T A B L E 1 Primers for Q-PCR
Primers Sequence
| 5099
| Statistical analysis
Results were expressed as mean ± SEM. Comparisons between groups were determined by Student's t test, or ANOVA. P < 0.05 was considered statistically significant. All experiments were repeated at least three times, and representative data are shown.
| RESULTS
| Lox inhibition enhances BMP4-induced osteogenesis
Several studies have demonstrated that BMP4 has a well-established role in triggering commitment of mesenchymal stem cells into the osteogenic and adipogenic lineage. [8] [9] [10] 15 In addition, BMP4-regulated osteogenic and adipogenic lineage commitment of MSCs is mutually exclusive. 8 Based on our previous studies that knockdown of Lox disrupts the BMP4-induced adipocyte lineage commitment from MSCs 10 and a theoretical inverse relationship exists between osteogenic and adipogenic lineage commitment and differentiation of MSCs, 6 we hypothesized that knockdown of Lox would enhance BMP4-induced osteogenesis of MSCs. To explore this, C3H10T1/2 cells, a well-characterized mesenchymal stem cells 20 
| CHOP-10 up-regulation contributes to the enhanced osteogenic lineage commitment by Lox inhibition
It has been previously reported that CHOP-10 inhibits terminal adipocyte differentiation in 3T3-L1 preadipocytes 23 and enhances osteoblastic differentiation in ST-2 stromal cells. 24 We next explored 
| Wnt/β-catenin signalling is involved in the enhanced osteogenesis by Lox inhibition or CHOP-10 overexpression
Next, we investigated the molecular mechanisms by which Lox and CHOP-10 regulates unbalanced adipogenesis and osteogenesis. We previously reported that BMP4 activates Smad and p38 MAPK signalling to induce Lox, which promotes adipocyte lineage commitment. 10 Here we found that Lox inhibition decreased phosphorylation of Smad1/5/8 and p38 MAPK induced by BMP4 ( Figure 3A) . In contrast, the Wnt/β-catenin signalling pathway, which is central to bone development and homoeostasis, 3, 25 was greatly activated by Lox inhibition ( Figure 3B ). We showed that Lox inhibition increased GSK-3β phosphorylation at Ser 9 and up-regulated β-catenin, while
Axin and total GSK-3β were both decreased ( Figure 3B 
| Lox inhibition enhances bone formation in vivo
The above results have shown that Lox inhibition enhances BMP4-induced osteogenesis in vitro. As we mentioned earlier, C3H10T1/2 cell line behaves similarly to mesenchymal stem cells, 20 were decreased ( Figure 4A ).
Next, we investigated whether Lox inhibition in conjunction with
BMP4 could enhance bone formation in vivo. Here, we use Fabp4-driven male BMP4-Tg to do the experiment for the following reason.
On the one hand, BMP4 is a secretory protein and has an endocrine effect. 27 Therefore, BMP-4 overexpressed by the adipose tissues might be released into serum and reach all tissues including bone.
On the other hand, BMP4 might be also overexpressed in bone of 
| Lox is up-regulated in obesity-induced bone loss
It has been demonstrated that male C57BL6 mice fed a high-fat diet was associated with a reduced rate of bone formation and turn- 
| DISCUSSION
Bone is an active tissue, undergoing continuous remodelling by orchestrated processes of osteoclastic bone resorption and osteoblastic bone formation. 33 Various conditions, such as osteoporosis, and HFD (n = 3) mice. NCD, normal chow diet; HFD, high-fat diet. E, Graphical abstract. *P < 0.05, **P < 0.01, *** P < 0.001, ****P < 0.0001 fracture and rheumatoid arthritis, occur because of loss of normal bone structure, function and homoeostasis. A complicated and controversial relationship exists between obesity and bone health. BMP4 function in bone is complex. 36 Recently, it has been demonstrated that increased circulating levels of BMP4 in obese human subjects and diet-induced obesity (DIO) mice, 37, 38 which is often accompanied with osteoporosis, suggesting a osteoporosis promotion role of BMP4. Furthermore, disruption of signalling through BMPR1A in adult osteoblasts or osteoclasts [39] [40] [41] increases bone mass provides evidence that alteration of the physiologic levels of BMPs and/or altering BMPR1A may have therapeutic effects on bone loss in vivo. Our findings reveal that Lox inhibition promotes BMP4-induced osteogenesis, which contradicts previous reports about the functions of Lox in bone development.
14, [42] [43] [44] Specifically, primary calvarial osteoblasts from Lox −/− mice exhibit decreased osteoblastic differentiation, 14 and BAPN inhibits osteoblastic differentiation of MC3T3-E1 preosteoblasts. 44, 45 This discrepancy may be owing to the presence of BMP4, a molecule with both pro-adipogenic and pro-osteogenic effect, in that BAPN alone inhibited osteogenesis both in vitro ( Figure S1 ) and in vivo ( Figure S5 ), which was consistent with the previous study that Lox inhibit osteoblast differentiation.
We have previously reported that BMP4 promotes adipocyte lineage commitment at a concentration that can also promote the osteogenic lineage commitment found in this study. Here, we It has been reported that Chop null mice exhibit decreased bone formation, indicating that CHOP-10 is crucial for osteoblastic function in vivo. 46 Here, we have demonstrated that CHOP-10 stimulates both basal and BMP4-induced osteogenesis ( Figure 2D-F and   S3A ), in agreement with previous reports using ST-2 stromal cells. 24 However, a previous study showed impaired osteoblastic function and osteopenia in transgenic mice overexpressing CHOP-10 because of increased osteoblast apoptosis. 47 We also found that CHOP-10 promotes BMP4-induced osteogenesis by hampering commitment to the adipocyte lineage of MSCs ( Figure S3B,C) . Additionally, we identified a reciprocal regulation between Lox and CHOP-10 ( Figure 2G-I ), providing possibilities for precisely regulating CHOP-10 so as to balance adipogenic and osteogenic differentiation. Generally, CHOP-10 is necessary for normal osteoblast differentiation, but when in excess and under specific conditions in vivo, it could be detrimental to bone homoeostasis.
The effects of Wnt/β-catenin signalling on bone mass have been well-established in both mouse models and human patients, 48 showing both pro-osteogenic and anti-adipogenic effects. 6 In addition,
there is an intricate crosstalk between Wnt/β-catenin and BMPs, The impact of obesity on bone health has been controversial for a long time. Obesity was traditionally viewed to be beneficial to bone health. 52 However, increasing evidence has shown that obesity could be a risk factor for osteoporosis. 52, 53 Here, we showed a significant bone loss in HFD-induced obesity mice ( Figure 5 ), in line with reports that obesity is associated with bone loss. 52 We also discovered an inverse correlation between Lox and bone markers in both NCD and HFD mice ( Figure 5 ). We detected higher expression of Lox, lower expression of CHOP-10 and Ocn and decreased bone formation in HFD mice femurs ( Figure 5D ), in line with reports that obesity is associated with decreased bone mass. 52 However, the mechanism underlying how Lox up-regulates CHOP-10 expression is yet to be uncovered.
In general, our study uncovered a novel Lox/CHOP-10 crosstalk governing the osteogenic and adipogenic cell decisions of MSCs. We demonstrated that Lox inhibition greatly enhances BMP4-induced osteogenesis, while suppressing the pro-adipogenic effect of BMP4 ( Figure 5E ). This could advance the clinical use of BMPs in bone diseases. Our study also provides a new path towards advancing the fundamental understanding of reciprocal connections between fat and bone tissue, presenting Lox as a promising target in prevention of bone and fat diseases.
